Metabolic

Latest News

Age-Related Differences in Plasma Cholestanol, Lathosterol Found in Pilot Study

There may be age-related differences in the plasma levels of cholestanol and lathosterol as well as in their respective ratios to cholesterol levels.

Olanzapine, Clozapine Show Worst Metabolic Effects Among Antipsychotics

Symptom reduction was significantly correlated with poor metabolic adverse effects, including weight gain, elevated BMI, and higher total cholesterol.

Lifestyle Intervention Improves Cardiometabolic Risk Factors in Women With PCOS

Researchers performed a systematic review and meta-analysis to summarize and update the evidence regarding the effects of lifestyle intervention, including diet, on cardiometabolic risk among overweight and obese women with PCOS.

Lipoprotein(a) Reduction With Alirocumab Found to Lower Cardiovascular Risk After ACS

The lowering of lipoprotein(a) with alirocumab was found to independently contribute to the reduction in major adverse cardiovascular events in patients with recent acute coronary syndrome.

Metabolic Syndrome May Increase Risk for VTE Recurrence After DVT

For patients with DVT, the presence of any component of metabolic syndrome is independently associated with an increased risk for VTE recurrence.

Tool Developed to Assess Long-Term CVD Risk, Benefit of Lipid-Lowering Intervention

The blood levels of non-high density lipoprotein cholesterol were found to have a strong association with the long-term risk for a cardiovascular disease event.

Diabetes Mellitus May Increase Risk for Developing Heart Failure

Increased risk for heart failure also seen in group of participants without diastolic dysfunction

High Lipoprotein(a) Is Risk Factor for CVD in Type 1 Diabetes

Lp(a) is a significant risk factor for macrovascular disease, albuminuria, and calcified aortic valve disease for patients with type 1 diabetes.

Poor Diet Contributes Substantially to Cardiometabolic Disease Costs

Suboptimal diet accounts for 18.2 percent of all cardiometabolic disease costs in the United States.

Examining the Associations Between Oral Nitrate-Reducing Bacteria and Cardiometabolic Outcomes

A greater quantity of oral nitrate-reducing bacteria was found to be associated with reduced plasma glucose and insulin resistance in young to middle-aged adults.